KELLY OSULLIVAN-STOBBE: Open Payments
NPI 1750372934 · APOPKA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$824 in 32 payments from 12 companies in 2025. Trend: 2023 $123 · 2024 $161 · 2025 $824
Food & beverage: $824
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $203 |
| Novo Nordisk Inc | 2 | $139 |
| AstraZeneca Pharmaceuticals LP | 5 | $118 |
| PFIZER INC. | 3 | $91 |
| Tris Pharma Inc | 4 | $84 |
| Exact Sciences Corporation | 2 | $43 |
| Corcept Therapeutics | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $33 |
| Acella Pharmaceuticals, LLC | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: Kerendia, Dyanavel XR, FARXIGA, ELIQUIS, Korlym, KEVEYIS, Ozempic, NURTEC ODT.
Industry payments across FL — which companies pay providers there.
